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Characterization of multimeric complexes formed
by the human PTB1 protein on RNA
CAROLINE CLERTE and KATHLEEN B. HALL
Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, USA

ABSTRACT
Polypyrimidine tract binding protein (PTB or hnRNP I) has several known functions in eukaryotic cells, including exon exclusion
during alternative splicing events, mRNA stabilization, and regulation of viral translation and replication. PTB contains four RNA
Binding Domains (RBDs, or RRMs), all of which can potentially bind RNA, but their roles in the various biological functions of
PTB are not clear. We investigate the properties of the complexes formed by human PTB1 on two target RNAs: the rat GABAA
receptor g2 subunit pre-mRNA and the Hepatitis C Virus 3¢ NonTranslated RNA. The GABA RNA contains four polypyrimidine
tracts in the intron and exon, while the HCV NTR contains a 75-nt U-rich tract and a highly structured 3¢-terminus. Electrophoretic mobility shift assays show that PTB1 protein first binds to both RNAs with nanomolar affinities, but subsequent protein
addition leads to formation of higher-order complexes. Stoichiometry experiments show that the ultimate complexes contain up
to eight PTB1 proteins per RNA strand. Protein constructs containing two tandem RBDs also bind the two RNAs, but with
different affinities and stoichiometries. Nuclease protection assays show that PTB1 protects the polypyrimidine tracts in the
GABA RNA, as does a construct consisting of RBD3 and RBD4; however, a construct containing RBD1 and RBD2 enhances
cleavage of bound RNA. The binding mechanisms of PTB1 are unique to the full-length protein; these modes appear to include
direct association with the RNA as well as weaker intermolecular protein associations.
Keywords: PTB1; polypyrimidine tract binding protein; HCV RNA; GABA pre-mRNA

INTRODUCTION
Polypyrimidine tract binding protein (PTB, also known as
hnRNP I) is ubiquitously expressed in eukaryotic cells, and
found in both the nucleus and cytoplasm. It functions in
pre-mRNA alternative splicing, where it acts as a regulator
of 3¢-splice site selection (Valcarcel and Gebauer 1997;
Wagner and Garcia-Blanco 2001; Black 2003). PTB protein
appears to act most often as a splicing repressor (resulting
in exon exclusion). The mechanism of repression by PTB is
not clear, and is complicated by the presence of three PTB
isoforms (PTB1, PTB2, and PTB4) (Wollerton et al. 2001)
and specific cellular proteins, all of which are differentially
expressed in tissues and developmental stages of the cell.
PTB is a modular protein, with four noncanonical RNA
binding domains (RBDs, or RNA Recognition Motifs,
RRM) that are tethered together by conserved linker
domains. There are NMR structures of all four RBDs
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(Conte et al. 2000; Simpson et al. 2004). RBD1 and RBD4
have the standard babbab secondary structure and adopt
an a/b sandwich tertiary fold with a four-stranded antiparallel b-sheet, characteristic of RBDs. RBD2 and RBD3 have
an unusual structure, for they have a fifth b-strand connected by a loop that passes over the surface of the b-sheet.
Since many RBDs use the b-sheet as the RNA-binding surface, the presence of this loop could impede access by the
RNA, especially in RBD2, where the loop appears in close
proximity to a portion of the b-sheet (Simpson et al. 2004).
It is not known if the RBDs function independently or
synergistically, nor is it understood how they are positioned
with respect to each other in the free protein or on an RNA
substrate. Back et al. (2002) report that during poliovirus
infection, the viral protease 3CDpro cleaves PTB within the
linker between RBD2 and RBD3; the PTB isoforms are
cleaved at different times during infection, and with different efficiencies. This separation of PTB into two fragments
suggests that each could be used as independent units by
the virus, and perhaps also by the cell.
As models of PTB interactions with different alternatively
spliced mRNAs, Wagner and Garcia-Blanco (2001) illustrate schemes for PTB association with a-tropomyosin, aactinin, GABAA g2, and c-src. Where possible, their
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schemes incorporate other proteins that have been implibowski 1997) is modulated in part by interactions between
cated in specific exon inclusion, but all models assume that
PTB and pre-mRNA including sequences within both
PTB binds directly to RNA, then PTB:PTB interactions
intron and exon. The sequence of the rat GABAA prestabilize a complex, creating what these authors call a
mRNA is shown in Figure 1A. Like many alternatively
‘‘zone of silencing’’; that is, refractory to splicing. Models
spliced pre-mRNAs, it has a complex primary sequence
of exon exclusion propose either that PTB proteins bound
around its 3¢-splice site. In addition to the (U/C)11 polyto polypyrimidine tracts in flanking introns interact with
pyrimidine tract between the 3¢-splice site and the brancheach other to position the excluded exon in a loop; or, that
point A, there is another upstream: a (U/C)34 tract,
PTB proteins bind in a long linear arrangement to cover
separated from (U/C)11 by an An sequence (n = 15 in rat).
both intron and exon. A recent study of c-src N1 exon
Additional (U/C)7 and (U/C)9 tracts occur in the exon.
regulation by PTB demonstrated that not only were flankSecondary structure predictions of GABA RNA show the
ing binding sites required for exon repression, but downintron to be predominantly single stranded (Fig. 1B), but
stream weak binding sites were required for conversion to
the exon could have significant secondary structure, includa multimeric complex (Amir-Ahmady et al. 2005). The
ing a UUCG tetraloop.
length, composition, and location of polypyrimidine tracts
HCV is a positive-strand RNA virus, and contains a
in alternatively spliced RNAs greatly vary, and will certainly
complex 3¢-NTR that is required for replication (Kolykhalead to different numbers of PTB proteins bound, as well as
lov et al. 1996, 2000; Friebe and Bartenschlager 2002).
different conformations of the complexes. The idea that
Kolykhalov et al. (1996) characterized the 3¢-NTR sequence,
several PTB proteins bind to these premRNAs to form a large complex is common to most models, but the specific
interactions between RNA and RBDs
and the sites of protein:protein interaction remain to be elucidated.
PTB does not function only in alternative splicing, and does not exclusively
reside in the nucleus. Among many
functions (Wagner and Garcia-Blanco
2001), it has been shown to stabilize
insulin mRNA (Tillmar and Welsh
2002; Fred and Welsh 2005), interact
with the EMCV (encephalomyocarditis
virus) Internal Ribosome Entry Site
(IRES) (Witherell et al. 1993), and, in
HCV (hepatitis C virus) is variously
reported as required for translation and
replication (Ali and Siddiqui 1995;
Chung and Kaplan 1999; Ito and Lai
1999; Anwar et al. 2000; Tischendorf et
al. 2004). A single model of complex
formation may not account for the
properties of all PTB:RNA complexes.
In this work, two RNAs that are normally bound by PTB are used as model
systems to investigate the properties of
the complexes. One RNA is the GABAA
receptor g2 pre-mRNA intron/exon; the
other is the 3¢-NTR (NonTranslated
Region) of HCV. These RNAs differ in
the sequence and length of their poly- FIGURE 1. (A) The GABAA receptor g2 pre-mRNA used in binding and stoichiometry
pyrimidine tracts, and thus represent experiments. A is the branchpoint adenosine; AG102/CU is the 3¢-splice site at the intron/
two potentially different binding modes exon junction; AG127/GU is the 5¢-splice site at the exon/intron junction. Putative UCUU PTBbinding sites are in bold, and the polypyrimidine tracts mentioned in the text are framed. (B)
of the protein.
Predicted lowest free-energy secondary structure (bioweb.pasteur.fr/seqanal/tmp/mfold) of the
Alternative splicing of the GABAA GABA g2 intron/exon sequence used in these experiments. Note the presence of a UUCG
receptor g2 subunit (Ashiya and Gra- tetraloop at nucleotide G110.
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FIGURE 2. (A) HCV 3¢-NTR sequence. NS5B sequences (in brackets), X sequences (underlined), and the different X RNA constructs used
in these experiments. Putative UCUU PTB-binding sites are in bold. (B) Predicted lowest free-energy secondary structure (bioweb.pasteur.fr/
seqanal/tmp/mfold) of the HCV 3¢-NTR sequence.

and showed that it could be subdivided: a hypervariable
region with no sequence conservation; a variable length
polypyrimidine tract (typically 70–120 nt); and an invariant
sequence (‘‘X’’) (Fig. 2B). PTB is clearly important to HCV
in the cell: in Huh7 cells (a human hepatocyte cell line)
transfected with the HCV replicon, the endogenous PTB
goes from the nucleus to the cytoplasm, where it colocalizes
with the viral NS5B protein (Domitrovich et al. 2005). PTB
has been reported to bind to both the U-rich polypyrimidine tract (Gontarek et al. 1999) and to X RNA (Tsuchihara
et al. 1997), and is thought to regulate replication (Domitrovich et al. 2005). Because the HCV 3¢-NTR contains
predominantly uridines, it represents another class of
PTB-binding sites, and therefore the binding, orientation,
and global topology of PTB proteins could be quite different from other RNA sequences.
Here, we compare binding affinity, stoichiometry, and
footprinting of full-length PTB1 protein and its three tandem RBD constructs (PTB1:12, PTB1:23, and PTB1:34) to
the 3¢-NTR of HCV and to a construct of the rat GABAA
receptor g2 pre-mRNA intron/exon.

RESULTS
PTB1 and GABAA receptor g2 pre-mRNA intron/exon
The GABAA receptor g2 (GABA) intron/exon (I/E) RNA
contains 75 nt of the upstream intron including the

branch site, all of the 24-nt alternatively spliced exon, and
29 nt of the downstream intron (Ashiya and Grabowski
1997).
EMSA assays

Binding to GABA RNAs by PTB1 and three PTB1 constructs (PTB1:12, PTB1:23, and PTB1:34) was observed
using electrophoretic mobility shift assays (EMSA) in native
8% polyacrylamide gels, run at 4 C. An increasing concentration of protein was added to a constant picomolar RNA
concentration in a binding buffer containing 100 mM
NaCl, 1 mM MgCl2, 10 mM sodium cacodylate (pH 7.0),
20 mg/mL BSA, and 10 mg/mL tRNA. Experiments were
also done in 50 mM NaCl and 250 mM NaCl; binding was
observed in both conditions, but to prevent nonspecific
association at the low salt, and gel artifacts at the higher
salt, standard conditions of 100 mM NaCl were used
throughout the experiments.
All PTB1 constructs bound to the GABA Intron/Exon (I/
E) RNA, albeit with different affinities, as shown in Figure
3. Note that while bands are fairly well-resolved in the
PTB1:RNA gel, the bands from PTB1:34 binding are more
smeared, suggesting that the complexes are either dissociating during electrophoresis, or that these complexes are
heterogeneous, with PTB1:34 binding at different positions
on the RNA. Such smearing made quantification difficult,
since bands could not be cleanly separated; the same behavior was observed in EMSA experiments with c-src RNA
www.rnajournal.org
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FIGURE 3. PhosphorImager EMSA data for binding to GABAA receptor g2 intron/exon (I/E) RNA; 100 mM NaCl, 1 mM MgCl2, 10 mM sodium
cacodylate (pH 7), 20 mg/mL BSA, and 10 mg/mL tRNA.

and PTB1:34 by Simpson et al. (2004). EMSA experiments
of Liu et al. (2002) also showed binding of PTB1 and
PTB1:12 to GABA I/E RNA (there called rGg57Bam), but
they did not observe binding by PTB1:34, using a virtually
identical protein construct. Perhaps the low crosslinking
ratio of their gel (80:1) did not allow good resolution of
these diffuse bands.
Because there are potentially four independent polypyrimidine tracts in GABA RNA, the sequence was subdivided
for binding experiments, in order to understand how each
sequence contributed to the total complex (Table 1). Binding of PTB1 and its constructs to these RNAs is summarized
in Table 2. Because most titrations produced several
(super)shifted bands, for comparison, the protein concentration is given at which the first shifted band was observed.
An unexpected result was that there was no binding
observed to the exon (E) alone, by any PTB1 construct,
despite the presence of two polypyrimidine tracts. The
UCUU sequence, which is thought to be a high-affinity
binding site (Perez et al. 1997b), is part of the (U/C)7
tract, which in the secondary structure prediction is part
of a UUCG tetraloop structure; apparently the remaining

UUUUCCUUC sequence [the (U/C)9 tract] in the exon is
insufficient for stable PTB1 binding, since an RNA oligonucleotide consisting of the (U/C)9 sequence (plus a 5¢gggac T7 polymerase start sequence) was not bound by
PTB1 in EMSA experiments (data not shown). This exceptionally stable UUCG element could sequester the (U/C)7
site from PTB, and therefore was removed by mutation of
its UUCG to UUCA in the background of the I11/E RNA
construct. This mutant I11/Em RNA was bound by PTB1
and PTB1:12 proteins at three times lower protein concentrations than was the wild-type I11/E, while PTB1:34 binding properties did not change, implying that PTB binding is
sensitive to RNA secondary structure.
Appearance of a first shifted band in EMSA experiments
provides a qualitative indicator of the affinity of a PTB
protein to RNA. As summarized in Table 2, PTB1:23 binding
is weakest, followed by PTB1:12; PTB1:34 binding often
shows a shift at a concentration similar to that of PTB1. In
an attempt to rescue the weaker binding of PTB1:34 to the
I11 RNA, the two PTB constructs, PTB1:34 and PTB1:12,
were combined in an equimolar mixture, then added to the
RNA; complexes were observed by EMSA. The band shifts

TABLE 1. GABA RNA constructs
I/E
---(A)15—A---&-I
----(A)15 —A--I34
----(A)15
I11—[
E44 ---&
E&
I11/E --A—&

I11/Em--A—&

5¢-AUUUGUCUUAUUUUGUUUCUCUUUCUCUCCUUUCCUUUUCCUUCUUCUUAUUAAAAAAAAA
AAAAAACUACGCAAUUCUCUUUUCUGUCUACAAAUCCAAAG/CUUCUUCGGAUGUUUUCCUUCA
AG/GUAUACUGUUUUUGGAAUGGGCAUUUCACG-3¢
5¢-AUUUGUCUUAUUUUGUUUCUCUUUCUCUCCUUUCCUUUUCCUUCUUCUUAUUAAAAAAAAAA
AAAAACUACGCAAUUCUCUUUUCUGU-3¢
5¢-AUUUGUCUUAUUUUGUUUCUCUUUCUCUCCUUUCCUUUUCCCUCUUCUUAUUAAAAAAA
AAAAAAAACUA-3¢
5¢-GGCGCAAUUCUCUUUUCUGUCUACAAAUCCAAAG/GUAAGU-3¢
5¢-GGACAAAUCCAAAG/CUUCUUCGGAUGUUUUCCUUCAAG/GUAAGU-3¢
5¢-AG/CUUCUUCGGAUGUUUUCCUUCAAG/GUAAGU-3¢
5¢-GGACUACGCAAUUCUCUUUUCUGUCUACAAAUCCAAAG/CUUCUUCGGAUGUUUUCCUUCAAG/GUAAGU-3¢
5¢-GGACUACGCAAUUCUCUUUUCUGUCUACAAAUCCAAAG/CUUCUUCAGAUGUUUUCCUUCAAG/GUAAGU-3¢

GABA RNA constructs used in EMSA and stoichiometry experiments. I/E is the Intron/Exon; I34 contains the intron (U/C)34 tract and A15; I11/E
contains the intron (U/C)11 and the exon; I11 contains the intron (U/C)11 polypyrimidine tract; E is the exon; E44 contains extra nucleotides from
the intron; I11/Em contains a G!A mutation in the UUCG tetraloop.
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TABLE 2. EMSA binding of PTB1 constructs to GABA RNAs

PTB1
PTB1:12
PTB1:23
PTB1:34

I/E

I

I34

I11

I11/E

Exon

I11/Em

2 nM (4)
7 nM (3)
90 nM (3)
1 nM (4)

1 nM (3)
70 nM (3)
450 nM (1–2)
5 nM (2)*

1 nM (3)
16 nM (2–3)
nd
8 nM (3)

3 nM (1)
0
0
84 nM (1)

15 nM (3)
500 nM (1)
90 nM (2)
4 nM (3–4)

0
0
0
0

3 nM (3)
190 nM (2)
nd
4 nM (>3)*

Protein concentrations are given that correspond to the first appearance of a shifted band on the gel; they are not dissociation constants. (nd) Not
determined; (0) no binding observed at protein concentrations from nanomolar to 3mM. Numbers in parentheses are the number of discrete
shifted bands observed. (*) Bands very diffuse, with no clear boundaries.

observed were nearly identical to those of PTB1:34 alone,
indicating that the addition in trans of the two halves of the
protein could not increase PTB1:34 affinity (data not shown).
Estimation of apparent dissociation constants

To obtain a semiquantitative value of the binding affinity of
PTB1 and its constructs to the various RNAs, the EMSA data
were analyzed assuming that each band represented a distinct
complex, but without any assumption of the stoichiometry.
Bands were separated and quantified using PhosphorImaging
software, and the RNA fraction bound in each complex as a
function of PTB concentration was used as input to fit to a
partition function for association (Origin 7.5; OriginLab,
Northampton, MA) (Table 3). Semiquantitative analysis of
EMSA data could not be performed with all complexes, and
only those experiments with sufficient data points to measure
initial complex formation were analyzed. In the fitting protocol, equilibrium association constants (K) and Hill coefficients
(n) were allowed to float simultaneously, recognizing that these
parameters are correlated. The values of n are interpreted to
indicate that a binding event is cooperative when ni > 1, independent (noncooperative) when ni = 1, and anticooperative
when ni < 1. (Goodness of fit of the function was determined
by eye to agreement with the data points, using Occam’s razor
to limit the number of parameters.) Because the number of
bound proteins corresponding to each band shift is unknown,
these values are apparent KAs and provide a relative comparison of the different PTB constructs and RNAs.

PTB1 binding to the GABA intron (I) RNA, with its two
polypyrimidine tracts (U/C)11 and (U/C)34, gives three
bands in EMSA experiments, only the first two of which
were analyzed (the third band is seen at 2.5 mM [PTB1])
(see Fig. 4). The data were best fit by the expression
P = 1 + (K1[P])n1 + (K1K2[P]2)n2,
where K1 and K2 are association constants for the two
bound species, and ni is the Hill coefficient. The first binding is characterized by a dissociation constant KD1 = 5 6 1
nM, with n1 = 2, indicating that this is a cooperative transition. The second band corresponds to noncooperative
binding with KD2 = 130 6 5 nM. PTB1:12 binding to
GABA I RNA produces three bands in EMSA experiments.
Fitting these data was best done using the partition function
P = 1 + (K1[P])n1 + (K1K2[P]2)n2 + (K1K22[P]3)n3,
where KD1 = 50 6 5 nM, n1 = 1, and KD2 = 300 6 20
nM, n2 = 1. In contrast to PTB1, binding by PTB1:12
does not exhibit cooperativity, indicating that its binding
mechanism differs from that of the full-length protein.
GABA I RNA is bound by both PTB1:23 and PTB1:34. As
shown in Figure 4E, PTB1:23 binding is quite weak, and
complicated by formation of complexes that do not enter the
gel. These data were not analyzed further. In contrast, PTB1:34
binding to GABA I is characterized by broad and smeary bands

TABLE 3. Dissociation constants for PTB1 constructs: GABA RNAs complexes
Protein
PTB1
PTB1:12
PTB1:34*

I
KD1 = 5 6 1 nM, n1 = 2
KD2 = 130 6 5 nM, n2 = 1
KD1 = 50 6 5nM, n1 = 1
KD2 = 300 6 20 nM, n2 = 1

I34
KD1
KD2
KD1
KD2
KD1
KD2

= 2 6 1 nM, n1 = 1
= 30 6 5 nM, n2 = 1
= 50 6 7 nM, n1 = 1
= 160 6 10 nM, n2 = 1.5
= 40 6 5 nM, n1 = 1.5
= 150 6 10 nM, n2 = 3

I11

I11/E

KD = 15 6 2 nM, n = 1.5

KD1 = 30 6 5 nM, n1 = 0.5
KD2 = 100 6 15 nM, n2 = 1.5

KD = 50 6 3 nM, n = 3

KD1 = 10 6 3 nM, n1 = 0.5
KD2 = 50 6 5 nM, n2 = 1
KD3 = 1 mM, n3 = 2.5

Data were obtained by allowing both n and K to vary simultaneously. (*) The values for I11/E are approximate, since resolution of individual
bands in the gel was difficult. Only one band was observed for I11; 100 mM NaCl, 1 mM MgCl2, 10 mM sodium cacodylate (pH 7), 20 mg/mL
BSA, 10 mg/mL tRNA, 4 C.
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FIGURE 4. Determination of the apparent binding constant for PTB1 and PTB1 constructs binding to GABAA receptor g2 intron RNA. (A,B,E,F)
PhosphorImager EMSA data for PTB1, PTB1:12, PTB1:23, and PTB1:34, respectively, binding to GABA I RNA. Note that EMSA data for PTB1:23
show nonspecific association with large complexes in the wells of the gel. EMSA data for PTB1:34 do not show distinct bands. (C) Dissociation
constants for PTB1 were calculated from the fit of the EMSA data to the partition function P = 1 + (K1[P])n1 + (K1K2[P]2)n2, where n is the Hill
coefficient and the Ks are the association constants, using Origin 7.5. (D) Dissociation constants for PTB1:12 were calculated from the fit of the
EMSA data to the partition function P = 1 + (K1[P])n1 + (K1K2[P]2)n2 + (K1K22 [P]3)n3.

(Fig. 4F), making quantification unreliable. In toto, binding to
the GABA I RNA serves to illustrate apparent variations in
binding modes and affinities of each PTB1 construct.
PTB1 binding to GABA I11/E [containing the (U/C)11
tract in the intron and two shorter tracts in the exon] also
showed three bands, but for analysis, only the two most
rapidly migrating species were analyzed (data not shown;
Table 3). Binding was best fit with the expression
P = 1 + (K1[P])n1 + (K1K2[P]2)n2,
462
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where KD1 = 30 6 5 nM, n1 = 0.5, and KD2 = 100 6 15
nM, n2 = 1.5. PTB1:34 binding is characterized by three or
perhaps four diffuse bands in the gel. Binding data were
analyzed assuming three complexes, using the function
P = 1 + (K1[P])n1 + (K1K2[P]2)n2 + (K1K22[P]3)n3
+ (K1K22K3[P]4)n4,
where KD1 = 10 6 3 nM, n1 = 0.5, and KD2 = 50 6 5 nM,
n2 = 1, and KD3 = 1 mM, n3 = 2.5.
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Formation of these complexes appears to occur via a first
event that is anticooperative, followed by subsequent cooperative binding with lower affinity. Anticooperative binding
is observed only on this RNA, and suggests that the exon
sequences are somehow responsible.
The GABA I34 RNA [containing (U/C)34 and (A)15] is
bound by PTB1, PTB1:12, and PTB1:34 proteins. Of the
three bands observed upon PTB1 binding, only the two
faster mobility complexes were analyzed (the third band at
highest protein concentration is in the well) using the
partition function
P = 1 + (K1[P])n1 + (K1K2[P]2)n2.
The data were fit with KD1 = 2 6 1 nM, n1 = 1, and
KD2 = 30 6 5 nM, n2 = 1. PTB1:34 binding to I34 RNA
shows three resolved bands; data were fit with
KD1 = 40 6 5 nM, n1 = 1.5, and KD2 = 150 6 10 nM,
n2 = 3, indicating cooperative binding mechanisms for
PTB1:34. PTB1:12 bound I34 RNA with affinities comparable to PTB1:34; weak binding is cooperative (n1 = 1.5), but
tight binding is not. Despite the similar values of dissociation
constants, PTB1:34 bound all the I34 RNA at 600 nM protein, whereas free RNA was still observed at 1.2 mM PTB1:12.
PTB1 and PTB1:34 binding to GABA I11 give only one
band in EMSA experiments (Fig. 5). PTB1:12 does not
detectably bind this RNA. PTB1 data were fit to
P = 1 + (K[P])n, where KD = 15 6 2 nM and n = 1.5,
indicating that binding is tight and cooperative. Using
the same expression for PTB1:34 affinity gives a highly
cooperative binding event (n = 3)
but a weaker dissociation constant
(KD = 50 6 3 nM). Again, these
data indicate that PTB constructs
exhibit distinct binding mechanisms.

tration needed to exceed that value. The limitation of the
stoichiometry experiments is that only the final state of the
complex with the greatest number of bound proteins will
be described, and not those intermediate states apparent
from EMSA experiments. For each stoichiometry experiment, the RNA [R] concentration was varied, typically
from 300 nM to 1 mM (always above the apparent KD)
to ensure that the final ratio of proteins bound per RNA
molecule did not depend on the total RNA concentration.
The concentration of protein [P] was increased from 0 to
10–20 mM, to give a sufficient range of [P]/[R] to reach a
plateau of binding; the value of [P]/[R] at the intersection
of the two portions of the titration is the stoichiometry of
protein binding to RNA. One example of the data is shown
in Figure 6; all results from stoichiometry experiments are
given in Table 4.
The stoichiometry data give an indication of the potential size of the complex formed by PTB on this GABA I/E
RNA, and how that complex is assembled. Clearly, the
complex formed is not simply the sum of separate complexes formed on the isolated polypyrimidine tracts. An
example of the nonadditivity is observed by a comparison
of the 6 6 1 PTB1 proteins bound to the intron (I) construct with the 6 6 1 PTB1 proteins bound to I34 plus the
two PTB1 proteins bound to I11 RNA. These data also
show that there is not a 1:1 correspondence between number of UCUU sites and number of PTB1 proteins bound.
UCUU was identified by Perez et al. (1997b) as a highaffinity binding site, and is colloquially used as an indicator
of PTB association. In the GABA I/E RNA, there are four

Binding stoichiometry

The overall stoichiometry of the complex was determined using nitrocellulose filter binding assays, where the
RNA concentration in an experiment
was held constant while the protein
was titrated. For these experiments, it
is important that the RNA concentration be at or above the apparent dissociation constant (KD), as distinct from
nitrocellulose filter binding assays conducted at low RNA concentrations that
are designed to determine the dissociation constant (Lohman and Mascotti
1992). Estimates of the dissociation
constants from EMSA data showed
that weakest binding was often micromolar, and therefore, the RNA concen-

FIGURE 5. Determination of the apparent binding constant for PTB1 and PTB1:34 binding to
GABA I11 RNA. (A,B) PhosphorImager EMSA data for PTB1 and PTB1:34, respectively.
Dissociation constants for (C) PTB1 and (D) PTB1:34 were calculated from the fit of the
EMSA data to the partition function P = 1 + (K[P])n.
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FIGURE 6. Stoichiometry determination of PTB1:34 bound to GABA
Intron/Exon RNA. [RNA] = 0.8 nM. Nitrocellulose filter binding ()
and fluorescence anisotropy (¤) data are superimposed.

UCUU sequences within the intron/exon, but eight PTB1
proteins can bind.
Fluorescence anisotropy and binding stoichiometry

PTB1:12, and PTB1:34 bound to GABA I/E RNA, and PTB1
and PTB1:34 bound to I11/E RNA. Proteins at 10 nM, 100 nM,
and 1 mM final concentrations were bound to RNAs in order to
approximate the complexes observed in EMSA experiments;
probing was done at 37 C. Dissociation constants were determined from reactions at room temperature and gels were run
at 4 C, so that the KD values at 37 C will be weaker; however, at
the PTB concentrations used, sequential formation of complexes should occur.
Binding of PTB1 to the GABA I/E showed progressive
protection of polypyrimidine tracts (Fig. 7A): at 10 nM
PTB1, the intron (U/C)11 tract appeared to be protected,
while partial cleavage of the flanking G87 and G72 was
observed. At 100 nM protein, (U/C)11 and (U/C)34 in the
intron were completely protected, as was (U/C)7 in the
exon. No cleavage at G87 and G72 was seen at 100 nM
PTB1. Strong cleavage of U48-U49 [just 5¢ to (A)15 in the
intron] was observed at 10 nM PTB1, but not at 100 nM
protein. Nuclease T1 and RNase A cleavage within the exon
was partially blocked at 100 nM PTB1. The cleavage patterns did not change in 1 mM PTB1. Liu et al. (2002) also
footprinted PTB1 on this RNA (1 mM PTB1 with 20 nM
RNA, using micrococcal nuclease as a probe), and noted the
protection of the (U/C)11 sequence as well as protection of
the tracts in the exon.
Footprinting of PTB1:12 on the GABA I/E did not show
protection of the (U/C)34 tract at 10 nM or 100 nM
protein, and only partial protection at 1 mM protein.
Cleavage after G87 and G72 occurs at all protein concentrations, as did cleavage at U48-U49 (Fig. 7A). Within the
exon, the T1 cleavage patterns closely resembled those seen
with denatured RNA, where cleavage occurs after all G
residues.
PTB1:34 bound to GABA I/E RNA protects the intron
(U/C)34 at 10 nM PTB1:34. Cleavage at the flanking U48U49 occurs even at 1 mM PTB1:34. Nuclease T1 cleavage
after G72 and G87 is diminished by addition of 1 mM

Another method to determine the stoichiometry of binding
to the GABA intron/exon (I/E) is to monitor the change in
fluorescence anisotropy of a fluorophore attached to the
RNA. Here, fluorescein is attached to d(T)16, which is
hybridized to the A15 sequence in the middle of the GABA
intron. No change in the total fluorescence intensity was
observed during these experiments, indicating that the dye
was not interacting with protein or RNA. The concentration of RNA used in these experiments was varied, always at
concentrations above the KD. An example of the data is
shown in Figure 6.
As shown in Table 4 and Figure 6, the stoichiometry of
binding determined by fluorescence anisotropy and nitrocellulose filter binding is in excellent
agreement for all PTB1 constructs.
Both methods show the same number
TABLE 4. Stoichiometry of PTB1 constructs bound to GABA RNAs
of PTB1 proteins bound to the GABA
RNA
intron/exon, within error: 8 6 1 proteins bound by filter binding, and 7 6 1
Protein
I/E
I
I34
I11
by fluorescence anisotropy. Similarly,
PTB1
(fb)
861
661
661
2
there are 8 6 1 PTB1:12 proteins and
(fa)
761
10 PTB1:34 proteins bound per GABA
PTB1:12
(fb)
961
961
861
0
I/E RNA. The agreement of these data
(fa)
861
shows that introduction of the 15-bp
PTB1:23
(fb)
10 6 1
nd
nd
nd
DNA:RNA duplex has not altered the
PTB1:34
(fb)
10 6 1
961
861
461
(fa)
10 6 1
binding mode of any protein.
Nuclease footprinting

Footprinting experiments with ribonuclease T1 and RNase A used PTB1,
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I11/E

I11/Em

3

3

0

nd

nd
561

nd
661

Values are [P]/[R], determined by nitrocellulose filter binding titration of protein into a fixed
concentration of RNA. (fb) Nitrocellulose filter binding; (fa) fluorescence anisotropy. [RNA]
varied from 500 nM to 1mM. I11/Em has a mutation to disrupt the UUCG tetraloop. A value
of 0 indicates no binding; (nd) not determined; 100 mM NaCl, 1 mM MgCl2 , 10 mM sodium
cacodylate (pH 7), 20 mg/mL BSA, 10 mg/mL tRNA, 21 C.
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FIGURE 7. (Continued on next page)
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protein, but is still present, as is cleavage of their flanking
C68-U69 and U88-C89-U90 nucleotides.
Protection of exon sequences is more easily seen using
the shorter I11/E RNA (Fig. 7B). Here, PTB1 partially
protects the two short tracts in the exon at 10 nM and
100 nM protein, and completely protects them at 1 mM
protein. The G102 and G110 nucleotides flanking the
(U/C)7 tract are partially protected by the full-length
protein. PTB1:34 binding protects (U/C)11 but allows
cleavage within the exon, even at 1 mM protein (Fig.
7B).
These data reveal a difference in the binding modes of
PTB1 and the two tandem constructs, as well as a difference between the two halves of the protein. Binding of
PTB1 extends into regions of the RNA that are not polypyrimidine tracts, as shown by protection of the flanking
purines and the exon sequences. PTB1:34 appears to protect polypyrimidine tracts in the intron, while PTB1:12
allows nuclease access even at 1 mM protein. This difference could be caused by the geometry of the RNA as it is
bound to the constructs, or to a difference in off-rates of
the proteins that allows more access to the RNA by the
nucleases.

HCV 3¢-NTR and PTB1
The full-length NTR construct used here contains 82 nt of
the NS5B gene, 46 nt of the hypervariable region, (U/C)75,
and ends with X. RNAs transcribed for these experiments
include the 310-nt NTR, the 98-nt X sequence, XSLI (Stem–
Loop I), XSLII/SLIII, and XSLIII.
Analysis of binding by EMSA

PTB1 and three PTB1 constructs (PTB1:12, PTB1:23, and
PTB1:34) bind to the complete 3¢-NTR as assessed by EMSA
(Fig. 8). Reaction conditions were selected from experiments
done over a range of NaCl concentrations from 50 to 500
mM and a pH range from 6 to 8. Binding was observed in all
solution conditions although with weaker affinity at 300 and
500 mM NaCl. Standard conditions for all assays are 100
mM NaCl, 1 mM MgCl2, 10 mM sodium cacodylate (pH
7.0), 20 mg/mL BSA, and 10 mg/mL tRNA.
The mode of binding of PTB1 and its constructs is not
the same: not only does the apparent affinity of the fulllength protein and its three constructs vary, but the migration patterns of the complexes are distinct (Fig. 8). The
clearest difference is observed with PTB1:34 binding, where

FIGURE 7. Footprinting of PTB1 and PTB1 constructs on GABA RNAs. Lanes T1 and A correspond to digestion with RNase T1 and A,
respectively. The control lanes are (—) no treatment; (OH) alkaline ladder; (T1 Ladder) RNase T1 under denaturating conditions. The G
ladder is shown on the left side. On the right side a schematic representation of GABA Intron/Exon RNA is displayed, where strong and
weaker protection sites by PTB1 are indicated by dark circles and open circles, respectively. (A) Footprinting of PTB1, PTB1:12, and
PTB1:34 on GABA Intron/Exon RNA. Enzymatic hydrolysis of 5¢-32P-GABA Intron/Exon RNA in the absence (free RNA) or in the
presence of 10 nM, 100 nM, or 1 mM of PTB1, PTB1:12, or PTB1:34. (B) Footprinting of PTB1 and PTB1:34 on GABA I11/E RNA.
Enzymatic hydrolysis of 5¢-32P-labeled GABA I11/E RNA in the absence (free RNA) or in the presence of 10 nM, 100 nM, or 1 mM of
PTB1 or PTB1:34. (C) Predicted lowest free-energy secondary structure of GABA Intron/Exon RNA. The (U/C)34, (U/C)11 tracts, and the
(A)15 are shown. AG102/CU 3¢-splice site and AG127/G128U 5¢-splice site at the intron/exon junction are shown in bold characters. T1
cleavage sites (G) are indicated by the open arrows.
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FIGURE 8. PhosphorImager EMSA data for HCV 3¢-NTR binding by PTB1 protein and PTB1:12, PTB1:23, and PTB1:34 protein constructs; 100
mM NaCl, 1 mM MgCl2, 10 mM sodium cacodylate (pH 7), 20 mg/mL BSA, 10 mg/mL tRNA, 4% polyacrylamide:bis 39:1 (50 mM tris/glycine at
pH 8.3), 4 C.

at low concentrations of protein, the mobility of the complex increases from that of the free RNA, consistent with a
compaction of the hydrodynamic volume of the complex.
PTB1:23 binding was characterized by formation of complexes that did not enter the gel. These complexes appeared
at the lowest protein concentration used (1.4 nM), and
became more pronounced as the protein concentration
increased. In no experiment was there observation of discrete bands of 3¢-NTR:PTB complexes.
PTB1, PTB1:12, and PTB1:23 binding to X RNA produced several discrete bands on the gel (Fig. 9). In
contrast, a single shifted species was observed when only
SLIII was bound. Binding to X and SLIII is quite weak
(micromolar), but this is not nonspecific binding (PTB1
does not bind to SLII of the human U1 snRNA in these
experiments) (data not shown). PTB1:34 did not bind to
either X or SLIII, as measured by EMSA experiments. No
construct bound to SLI, or to SLII/SLIII; the absence of
binding to the latter can be best explained by the ability of
this RNA to adopt secondary structures that block access
by PTB1.

PTB1 and PTB1:12 differed by a factor of 6 [KD(PTB1) =
285 6 120 nM; KD(PTB1:12) = 1.6 6 0.6 mM].
Stoichiometry experiments

Upon demonstration of RNA:protein interaction via
EMSA, and a qualitative determination of the apparent
dissociation constant, the stoichiometry of the complex
was determined using nitrocellulose filter binding. The
results are given in Table 6.
Six PTB1 proteins, eight PTB1:12 proteins, and 15
PTB1:34 proteins can bind to the 3¢-NTR. Only one
PTB1 protein binds to SLIII, while two associate with X.
The different stoichiometries illustrate that on this RNA,
too, there is a difference in the binding modes of PTB1 and
its two halves. Perhaps PTB1:34 proteins prefer Un
sequences, whereas PTB1:12 RBDs prefer mixed U/C
sequences. Alternatively, the physical binding modes of
PTB1:34 and PTB1:12 could differ significantly, such that
PTB1:34 is able to pack closely on the RNA.
Nuclease footprinting of X RNA

Dissociation constants

To measure the affinity of binding to X RNA, the bands
observed in the EMSA experiments were analyzed, and the
data fit by the partition function
P = 1 + (K1[P])n1 + (K1K2[P]2)n2.
Association constants (K) and the Hill coefficient (n)
were allowed to float (see Table 5).
The dissociation constants of PTB1 and PTB1:12 to X RNA
are weak and the same within error (800 nM and 1 mM;) (Fig.
9). The data were best fit with n = 1, indicating independent
binding events. Binding to SLIII was determined by nitrocellulose filter binding, since the stoichiometry of association
showed it to be 1:1. In these experiments, the affinities of

To map the sites on X that are protected by PTB1 binding, 1
mM PTB1 was used, based on the weakest KD of binding
(Fig. 10). One protected region is within SLIII, C7-UCC10-AUCU-U15; the other, U31-AGCUGU-G38, is in
SLII. These protected sequences correspond to the loops
of SLII and SLIII in the structure of X as mapped by Blight
and Rice (1997).

DISCUSSION
The results described here provide a new perspective on the
complexes formed by PTB protein on its RNA substrates.
First, formation of these complexes occurs sequentially: the
first proteins bind with 1–10 nM affinity; then proteins with
100–400 nM affinity; and finally, there is a class of proteins
www.rnajournal.org
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The first PTB1 proteins to associate
with the GABA RNAs do so with nanomolar affinity, certainly through direct
association with the RNA. As nuclease
protection assays show, the RNA is protected from cleavage at 10 nM PTB1
protein, a pattern that is not appreciably
altered as more protein is added. This
association presumably corresponds to
the first shifted band in EMSA experiments, although there are currently no
data that identify the stoichiometry of
this tightly associated complex. Subsequent secondary addition of PTB1 is
likely to occur through protein:protein
interactions, although a weaker binding
class of direct RNA:protein interactions
cannot be ruled out. These complexes,
observed as supershifted bands in EMSA
experiments at 100–300 nM PTB1 concentrations, are stable in 100 to 250 mM
NaCl in EMSA experiments at 4 C.
There are no data to describe either the
physical distribution of PTB1 proteins
in these complexes, or to characterize
the number of proteins associated. Heterogeneity of the physical morphology
or binding stoichiometry could lead to
broad bands in the gel, similar to those
observed for many complexes. The final
tertiary complexes occur at the highest
(micromolar) concentrations of protein, and have considerably weaker dissociation constants; preliminary data
show that these complexes are not stable
at 250 mM NaCl, suggesting that the
FIGURE 9. Determination of the apparent binding constant for PTB1 and PTB1 constructs interactions are predominantly electrobinding to the X RNA. (A,B,E,F) PhosphorImager EMSA data for PTB1, PTB1:12, PTB1:23, and
PTB1:34, respectively, binding to X RNA. EMSA data for PTB1:23 show a nonspecific association; static. We suggest that this third class of
PTB1:34 does not bind. Dissociation constants for (C) PTB1 and (D) PTB1:12 were calculated binding occurs through protein:protein
from the fit of the EMSA data to the partition function P = 1 + (K1[P])n1 + (K1K2[P]2)n2.
association, and is facilitated by a conformational change of PTB1 when it
binds to RNA, thus exposing some porthat associates with micromolar affinity. Second, the physition of the protein for subsequent interactions. This
cal mode of RNA binding by PTB1 differs from that of
hypothesis will be tested using fluorescence methods that
either PTB1:12 or PTB1:34, and the binding mode of
monitor independent domains of PTB1.
PTB1:12 differs from that of PTB1:34. Third, stoichiometry
The tandem RBD constructs of PTB1 also exhibit shifted
of association shows that formation of the largest comand supershifted bands in EMSA experiments, indicative of
plexes involves multiple PTB proteins bound to an RNA.
sequential association of protein to the complexes. Bands of
GABA RNAs bound to PTB1:12 are typically well resolved and
reasonably sharp, suggesting a uniform distribution of complexes is present in a band. PTB1:23 complex formation is
Ordered assembly of PTB:RNA complexes
difficult to assess critically, since much of the RNA in EMSA
EMSA experiments with the various GABAA receptor g2
experiments remains in the well of the gel. While such a result
RNA constructs show clear evidence of formation of large
sometimes indicates formation of extremely large particles
complexes through sequential addition of PTB proteins.
that cannot enter the gel matrix, these intractable PTB1:23–
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TABLE 5. Apparent dissociation constants calculated for PTB1 and
PTB1:12: HCV X RNAs
RNA
Protein
PTB1
PTB1:12

X RNA
KD1
KD2
KD1
KD2

= 800 nM, n = 1
= 1 mM, n = 1
= 800 nM, n = 1
= 1 mM, n = 1

X SLIII
KD = 285 nM 6 120 nM
KD = 1.6 mM 6 0.6 mM

For protein binding to X RNA, dissociation constants were calculated from the relation P = 1 + (K1[P])n1 + (K1K2 [P]2)n2, where n is
the Hill coefficient, using Origin 7.5 (OriginLab, Northampton,
MA). Binding to X SLIII was measured using nitrocellulose filter
binding, and the data were fit by Kaleidegraph to KD = ([R] –
[PR])([P] – [PR])/[PR]; 100 mM NaCl, 1 mM MgCl2 , 10 mM cacodylate (pH 7), 20 mg/mL BSA, 10 mg/mL tRNA.

conditions that favor electrostatic interactions (Oberstrass
et al. 2005). Photochemical crosslinking is most commonly
observed between RNA and RBD3 and RBD4 (Kaminski et
al. 1995; Perez et al. 1997a; Oh et al. 1998; Charlet et al.
2002). In experiments with independent RBD constructs,
RBD3 was shown to bind to polypyrimidine tracts (Oh et
al. 1998; Perez et al. 1997a). Simpson et al. (2004) used a
short RNA, CUUCUCUCU, to look for interactions with
RBD1 and RBD2 by NMR chemical shift mapping (100
mM NaCl, 50 mM sodium phosphate at pH 6.5), and
found chemical shift changes in both RBDs, the most dramatic being in RBD1. Amir-Ahmady et al. (2005) mapped
UV crosslinks to RNP-2 of RBD4 and a portion of the
linker between RBD3 and RBD4, and also detected 4thiouridine crosslinks to RBD1. In addition, both RBD4
and RBD1 were crosslinked to the oligonucleotide CUUCUCUCUCUG; those investigators suggest that both RBDs
contact this RNA simultaneously. However, our experiments show that the physical context of the RBDs within
PTB1 as well as the specific RNA sequence bound can and
do lead to different binding modes of the different RBDs.
A demonstration of the relation between RNA bound and
RBD context is readily seen by our experiments with PTB
binding to progressive truncations of the GABA intron RNA.
All four protein constructs bound to the entire 100-nt intron.
Although all four protein constructs also bound to the 70-nt
intron [I34 containing the (U/C)34 tract but missing the (U/
C)11 tract], binding by PTB1:12 and PTB1:34 was significantly
weaker. Finally, the 38-nt intron sequence (I11) containing
the (U/C)11 tract was bound by PTB1 and PTB1:34, but not by
PTB1:12. These polypyrimidine tracts are predicted to be
single stranded, and thus present a uniform structural context
for protein binding, yet the different protein constructs selectively associate with RNAs.
Another demonstration of the interdependence of RBD
context and RNA binding site comes from binding of the
protein constructs to the highly structured 98-nt HCV X
RNA. In previous reports of PTB1 binding to X, Tsuchihara
et al. (1997) reported that PTB binds to the 5¢-stem/loop

RNA complexes are observed at nanomolar concentrations of
protein, suggesting some hydrodynamic property of these
complexes interferes with their mobility. In contrast,
PTB1:34 readily associates with RNAs, but typically results
in shifted and supershifted bands that are broad and difficult
to separate. While the first high-affinity complexes to appear
on the gel are often well defined, subsequent shifted bands are
diffuse. These data show that all PTB1 constructs are capable
of forming hierarchies of complexes, but that the physical
properties of those complexes are not identical.
There are currently no data to describe how many tandem
RBD constructs are associated with any of the intermediate
complexes observed in EMSA experiments. PTB1:34 binding
to nearly all RNAs displays the greatest apparent heterogeneity
in the composition and/or structure of its complexes, thus
making them the most problematic to describe. Smeared
bands can result from dissociation of the RNA during electrophoresis; structural heterogeneity of complexes with a constant stoichiometry, leading to variation in their
electrophoretic mobility; or complexes that contain varying
numbers of bound PTB1:34 proteins, leading to different
charge to mass ratios, and hence to varying mobility.
PTB1:34 has been shown to be generated
through proteolytic cleavage by the polio
protease 3CDpro (Back et al. 2002), the
TABLE 6. Stoichiometry of PTB1 constructs bound to HCV 3¢-NTR RNA constructs
implication being that the virus has
found a function for this construct. It is
RNA
therefore especially important to identify
Protein
3¢-NTR
X RNA
SLI
SLII/SLIII
the cause of the diffuse bands in
PTB1:34–RNA gels, in order to correctly
PTB1
661
2
0
0
describe the properties of the complexes.
PTB1:12
861
2
0
0
PTB1:23
PTB1:34

PTB1 and its subdomains do not
share a binding mode
All RBDs are capable of association with
short RNA oligomers, at least under

2a
15 6 1

0
0

0

0

SLIII
1
1
0

Binding of PTB1 protein constructs to the 3¢-NTR of HCV and X constructs. Binding in 100
mM NaCl, 1 mM MgCl2, 10 mM sodium cacodylate (pH 7), 20 mg/mL BSA, 10 mg/mL tRNA.
a
This result is anomalous. EMSA experiments showed that most of the RNA was found in the
well of the lanes at PTB1:23 concentrations >22 nM. This complex appears to have a tangled
superstructure with an unknown stoichiometry.
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FIGURE 10. Footprinting of PTB1 and PTB1:12 on X RNA. Lanes T1 and A correspond to digestion with RNase T1 and A, respectively. The
control lanes are (—) no treatment; (OH) alkaline hydrolysis ladder; (T1 Ladder) RNase T1 under denaturating conditions. The G ladder is shown
on the left side. (B) Predicted lowest free-energy secondary structure of the X RNA. Positions cleaved by RNase T1 (open arrows) and by RNase A
(dark arrows) are shown. Changes in cleavage intensity upon PTB1 and PTB1:12 proteins are indicated by a dark dot (protection) or an open dot
(enhanced).

(SLIII) of the conserved X structure. A similar conclusion
came from work by Ito and Lai (1997) and Chung and
Kaplan (1999), except that those investigators concluded
that both SLII and SLIII were required. Our experiments
partly support previous binding studies, but also quantify
association: two PTB1 molecules bind weakly and independently to the complete X RNA; one PTB1 protein binds to
SLIII RNA. Two PTB1:12 proteins also bind independently
to X RNA, and only one PTB1:12 protein binds to SLIII. In
contrast, PTB1:34 does not bind to either X or SLIII, indicating that these RNAs do not provide an appropriate target
site for this construct.
Models of PTB1:34 binding to RNA

To reiterate our data briefly, we found that 15 (61)
PTB1:34 proteins, 8 (61) PTB1:12 proteins, and only 6
(61) PTB1 proteins are in the largest complex with HCV
3¢-NTR. PTB1:34 binds to GABA I11 RNA with its (U/C)11
470
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tract, but not to the HCV X hairpin or isolated SLIII.
PTB1:34 at least partially protects bound polypyrimidine
tracts from nuclease cleavage. We suggest that this construct preferentially binds single-stranded U-rich RNAs,
using both RBDs to contact the RNA.
The structural form of the protein in physiological conditions will determine how it is situated on the RNA strand.
Two examples of tandem RBDs that interact with RNA
illustrate the variation possible. In a cocrystal of two
RBDs of poly(A) binding protein bound to (rA)11, the
RNA stretches along the b-sheet surface of the RBDs, and
also makes contact with the nine-amino-acid linker
between the two domains (Deo et al. 1999). In a structure
of nucleolin determined by NMR, an RNA hairpin loop sits
between two RBDs, making interactions with both b-sheet
surfaces and the linker (Allain et al. 2000). The linkers
between the PABP and nucleolin are short, facilitating
RNA contact with both RBDs; the linker between PTB1
RBD3 and RBD4 is approximately three times longer. We
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predict that the disposition of RNA on the PTB1 RBDs will
vary with the sequence of the RNA.
PTB1:34 is a monomer in solution, as shown by NMR
(Conte et al. 2000) and equilibrium analytical ultracentrifugation (in 250 mM NaCl) (Simpson et al. 2004). In the
100 mM NaCl conditions of Conte et al.’s (1999) NMR
experiments as well as in our 15N NMR experiments in 100
and 200 mM KCl (data not shown), the two RBDs of
PTB1:34 tumble independently. However, in conditions of
low salt (30 mM NaCl), Oberstrass et al. (2005) found
interactions between the helices of RBD3 and RBD4, forcing the two b-sheet surfaces to face outward and away from
each other. Based on our data, we propose that the dominant binding mode for this construct allows the two RBDs
of PTB1:34 to close like a clam over the bound RNA, such
that both b-sheet surfaces and the 23-amino-acid linker
between the two domains make contact with the RNA.
We will test this prediction using NMR and fluorescence
methods, making use of specific mutations within the
RBDs.

any pyrimidine tract of appropriate length. Because RBD3
and/or RBD4 have less stringent requirements of RNA
length and RNA sequence, we propose that in the context
of the intact PTB1 protein, PTB1:34 initiates RNA binding
to single-stranded polypyrimidine tracts, bringing the RNA
into proximity of PTB1:12, which then, in turn, binds RNA
if the sequence is appropriate. It is possible that RBD3/
RBD4 could bind to a site that has no contiguous binding
site for RBD1/RBD2, thus forcing these RBDs to either
remain free in solution, or bind to a distal RNA site.
Assuming that the two halves of the protein have independent motion, facilitated by the 90-amino-acid linker
between RBD2 and RBD3, then this is a mechanism to tie
two regions of an RNA together in a compact complex.
Conversely, if a binding site is favored by RBD1/RBD2
(such as the stem–loops in X RNA), then RBD3/RBD4 is
free to bind other RNA sites, facilitating intermolecular
RNA association or intramolecular RNA looping.

Models of PTB1:12 binding

The two RNAs used in these experiments have either one
very long polypyrimidine tract or several juxtaposed tracts.
PTB1 forms large, multimeric complexes on both RNAs,
but the number of PTB1 proteins in the complex cannot be
predicted from RNA length alone. If there were such a
linear relationship, then the 75-nt U-rich tract in the HCV
RNA should bind twice as many PTB1 proteins as the (U/
C)34 tract in the GABA intron; in fact, six PTB1 proteins are
found in both complexes. More generally, a minimum
binding site size for PTB is not well defined. The sequence
5¢-(U/G)CYGCCUG(Y/G)UGCYYYYCYYYYG(Y/G)CCC3¢ (Y is pyrimidine), was selected as a target in SELEX
experiments with PTB1 (Singh et al. 1995). In contrast, a
UCUU tetramer was identified as a PTB target by Perez et
al. (1997b) but was not bound by PTB1:34 in NMR experiments (Yuan et al. 2002). Amir-Ahmady et al. (2005) found
that a 38-nt RNA containing the 10-mer CUUCUCUCUC
was a minimum length for binding by PTB1, which gave a
single band in EMSA experiments. That RNA construct is
similar in length and sequence to our GABA I11, which also
gave a single band in EMSA experiments; however, our
stoichiometry experiments showed it to contain two PTB1
proteins that bound cooperatively. Currently, we are unable
to predict the number of PTB1 protein constructs that can
ultimately associate with an RNA.
The global structure of the complexes could vary considerably, from long linear arrangements of PTB on contiguous polypyrimidine tracts to the looped out
arrangements envisioned by Wagner and Garcia-Blanco
(2001) and Amir-Ahmady et al. (2005). Models of PTB
interaction with pre-mRNA have been proposed in which
PTB complexes block access to bound RNA by steric exclusion (e.g., Wagner and Garcia-Blanco 2001), and on the
basis of the stoichiometry measured here, the density of

Three properties of PTB1:12 binding to the HCV 3¢-NTR
differ fundamentally from PTB1:34 binding. First, only half
the number of PTB1:12 proteins are bound; second,
PTB1:12 binds to the X RNA; and third, bound RNA is
exposed to nuclease digestion. Of the two RBDs in PTB1:12,
previous experimental data clearly identify RBD1 as an
RNA-binding site. Oh et al. (1998) demonstrated RBD1
binding to a portion of the EMCV 5¢-NTR in EMSA experiments; NMR chemical shift mapping (Simpson et al. 2004)
showed that RBD1 alone associates with a CUUCUCUCU
oligomer; and Amir-Ahmady et al. (2005) crosslinked
RBD1 to c-src RNA. RBD1, uniquely among the four
RBDs in PTB, contains an aromatic amino acid in the
conserved RNP1 sequence. Data supporting association of
RBD2 with RNA are less compelling (e.g., Simpson et al.
2004; Oberstrass et al. 2005); its unusual structure includes
a loop connecting b4 to b5 that lies on and partially
occludes the b-sheet surface. Our current model for
PTB1:12 binding is that RBD1 interacts directly with
RNA, and can bind either a single strand or a loop structure. RBD2 or the linker between RBD1 and RBD2 may
provide some electrostatic binding energy, but RBD2 is not
the dominant site of RNA contact. Furthermore, we propose that there is a conformational change of the PTB1:12
construct upon RNA binding that facilitates intermolecular
protein:protein interactions.
Model of PTB1 binding mode

On the basis of binding to the U-rich HCV RNA and the U/
C GABA polypyrimidine tracts, we suggest that PTB1:12
requires both cytosine and uridine nucleobases (with perhaps some sequence preferences), while PTB1:34 binds to

PTB:RNA complexes can be large
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PTB proteins on the RNA could certainly occlude binding
by other proteins. However, as the nuclease protection data
indicate, RNAs with noncontiguous polypyrimidine tracts
would have intervening uncovered RNA sequences, allowing access by other proteins.
Other cellular proteins are implicated in the modulation of PTB function. Some have been identified that
appear to associate with PTB and act in synergy to form
RNA:protein complexes: for example, hnRNP L (Hahm
et al. 1998) and raver1 (Gromak et al. 2003a). In contrast, CELF proteins appear to compete with and/or
displace PTB (Zhang et al. 1999; Gromak et al. 2003b).
A neuronal homolog of PTB, nPTB, is reported to
antagonize PTB binding (Markovtsov et al. 2000; Polydorides et al. 2000). Regulation by other proteins will
depend on the relative affinities of protein:protein and
RNA:protein interactions, and the relative concentrations of the proteins in the vicinity of the RNA.
More detailed study of formation and dissociation of
PTB:RNA complexes is necessary to determine how they
can be stabilized by binding partners or destabilized by
antagonists.
The largest complexes are formed after consecutive addition of PTB proteins to the RNA. It is important to emphasize that the disposition of proteins in these complexes is
not known, neither is it clear whether the large complexes
ultimately formed are due to direct RNA:PTB binding only
or include intermolecular protein interactions. The orientation of individual RBDs in the complexes is also unknown:
two contrasting scenarios either allow contiguous RNA
binding by all RBDs in a single PTB molecule or restrict
RNA binding to a single RBD, leaving other RBDs free to
associate with other proteins or other RNA sequences. The
geometry and dynamics of the protein domains in these two
limiting cases will be distinctive (and distinguishable by
time-resolved fluorescence probing of labeled proteins),
and would have consequences for the function of PTB as
it associates with a specific RNA.

at amino acid 183 and terminates at amino acid 439; PTB1:34
begins at amino acid 334; numbering refers to the human PTB1
sequence.

Protein purification
Individual clones were grown overnight at 37 C in LB/Kanamycin
(50 mg/mL) followed by 50-fold dilution into terrific broth (TB),
and grown at 37 C to an OD600 of 0.7. IPTG was then added to a
final concentration of 1 mM, and growth continued for 4 h. Cells
were pelleted by centrifugation at 6500 rpm for 15 min and frozen
at 80 C. The cell pellet was resuspended in 3 volumes of buffer A
(50 mM sodium phosphate, 300 mM NaCl, 10% glycerol at pH 8).
For lysis, cells were incubated at 4 C for 30 min with 5 mg/mL
lysozyme, 1 mM PMSF, 5 mg/mL Pepstatin, and protease inhibitor
cocktail (Sigma P2714) containing 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), trans-epoxysuccinyl-L-leucylamino(4-guanidino)butane(E-64), bestatin, leupeptin, aprotinin, and EDTA.
Cells were then pulse-sonicated for 30 sec five times with cooling
between. Cellular debris was removed by centrifugation at 10,000g
for 30 min at 4 C. The supernatant was removed and mixed with
the pre-equilibrated Ni-NTA resin (QIAGEN) in buffer A and
rocked at 175 rpm for 1.5 h on ice. The resin was then washed
four times for 10 min each with 25 mL of buffer A plus 20 mM
imidazole followed by elution of the protein with a gradient of
imidazole (0 mM–250 mM). PTB1:34 was purified using the
protocol described in Showalter and Hall (2004). Peak fractions
were collected, concentrated, and exchanged into storage buffer
(20 mM sodium cacodylate, 100 mM KCl, 0.5 mM DTT, 0.5 mM
EDTA, 10% glycerol) using a Vivaspin with the appropriate molecular weight cutoff.
Protein purifications were assessed by SDS-PAGE. Protein concentrations were determined by the absorption spectrum, using
e280 = 12,800 cm1 M1 (PTB1); 10,480 cm1 M1 (PTB1:12),
9080 cm1 M1 (PTB1:23), and 2560 cm1 M1 (PTB1:34).
Protein secondary structure was measured by CD spectroscopy
to confirm that the proteins were folded.

RNA transcription and purification
GABAA receptor 2 pre-mRNA

MATERIALS AND METHODS
Cloning
The human PTB1 gene cloned in pET 28A vector was a generous
gift from Doug Black (UCLA). Standard PCR methods were used
to generate each PTB1 RBD tandem construct (PTB1:12,
PTB1:23, and PTB1:34, where PTB1 is the isoform and 12, 23,
34 designate the RBDs in the construct). The different PCR
fragments were cloned in the pET28A vector using EcoRI and
HindIII restriction sites. Each clone was verified by sequencing.
Protein overexpression in Escherichia coli BL21(DE3) (Stratagene) was checked by induction with 1 mM IPTG. PTB1:34 did
not have a his-tag, and was cloned into a ptac2 vector with NcoI
and HindIII.
PTB1 contains the N-terminal 70-amino-acid NLS, as does
PTB1:12. PTB1:12 terminates at amino acid 300; PTB1:23 begins
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Plasmid RG g57 containing the GABAA receptor g2 pre-mRNA
construct was generously provided by Paula Grabowski (University of Pittsburgh, PA). The sequence was cloned downstream of a
T7 RNA polymerase promoter in a pBS vector. Plasmids were
linearized with either BamHI for the Intron/Exon or AccI for the
Intron. Other RNAs were transcribed from oligodeoxynucleotides,
using the method of Sampson and Uhlenbeck (1998).
HCV 3¢-NTR RNA
The RNA sequence was cloned downstream of the T7 RNA polymerase promoter in a pBR322 derivative, pTET (Keril Blight,
Washington University School of Medicine, St. Louis, MO). Plasmid DNA was linearized with either ScaI for the full-length HCV
RNA and the X RNA, or SmaI for X RNA DSLI. X SLIII RNA was
transcribed from oligodeoxynucleotides with T7 RNA polymerase.
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In vitro transcription reactions were done using T7 RNA
polymerase (Epicenter) in 40 mM Tris (pH 8.0), 1 mM spermidine, 6 mM MgCl2 with or without [a-32P]UTP and/or
[a-32P]CTP. After phenol extraction and ethanol precipitation,
RNAs were purified from denaturing polyacrylamide gels. The
RNA was eluted from the gel by incubation in 0.3 M sodium
acetate (pH 5.3) at 37 C overnight. Concentrations of unlabeled RNAs were determined spectrophotometrically using the
approximation of 1 A260 = 40 mg/mL RNA. Each sample was
heated at 95 C and snap-cooled on ice to generate the secondary structures.

Gel mobility shift assays (EMSA)
For gel mobility shift assays, folded [a-32P]RNA (200 cpm) in 10
mM KCl and 10 mg/mL yeast tRNA (Boehringer) was mixed with
the recombinant PTB proteins (1 nM–5 mM) in 10 mM sodium
cacodylate, 50 mM–500 mM NaCl, 1 mM MgCl2, and 20 mg/mL
BSA (pH 6–8). All reaction components were incubated for 30
min at room temperature. Glycerol was added to 10%, then reactions were loaded on 8% (GABA) or 6% (HCV) polyacrylamide
gels (40:1 acrylamide:bis) in 50 mM Tris-HCl/Glycine buffer and
run at 7 V/cm at 4 C for 3–4 h. Experiments were repeated at least
three times, using different preparations of RNAs and different
preparations of purified protein.

Filter binding stoichiometry
Nonradioactive RNA was mixed with a trace of [a-32P]RNA to
a final concentration of 0.1 mM, 0.5 mM, or 1 mM RNA. The
RNA was folded in solution by heating in water to 95 C,
quenching on ice, then addition of KCl to a final concentration of 10 mM and yeast tRNA to a final 10 mg/mL tRNA.
Increasing amounts of recombinant PTB1 proteins were incubated with the fixed concentration of RNA in 10 mM sodium
cacodylate, 100 mM NaCl, 1 mM MgCl2, and 20 mg/mL BSA
(pH 7). The reaction was incubated at room temperature for
30 min in a polypropylene microtiter plate (96 wells). Reactions were filtered through pre-soaked Schleicher and Schuell
0.45-mm nitrocellulose filters (Wong and Lohman 1997). Data
were analyzed with Kaleidegraph (Synergy, Inc.).

Anisotropy measurements
Anisotropies were measured using the L-format method on an
SLM 8100 spectrofluorometer. Anisotropy values were determined
using the following equation:
r¼

Ill  GI?
Ill þ 2GI?

where I|| and I? are the intensities of the fluorescence components
polarized parallel and perpendicular, respectively, to the vertically
polarized excitation beam. The G factor (here G = 1) corrects for
the polarization-dependent properties of the detection system. For
fluorescein RNAs, the anisotropy was measured with 490 nm
excitation (bandwidth 2 nm) and polarization fluorescence was
measured at 525 nm (bandwidth 4 nm). Before each acquisition,
samples were allowed to equilibrate for 15 min at 25 C in the
water-jacketed cuvette. Each anisotropy measurement was
repeated until the standard deviation of the measurement was
<0.001.

Nuclease footprinting
5¢-32P-labeled RNAs were folded by heating to 95 C in water,
quenching on ice, then adding KCl to a final concentration of 10
mM and tRNA to a final concentration of 20 mg/mL. To produce a
base hydrolysis ladder, RNA was incubated in 0.1 M sodium
carbonate (pH 9.3) at 100 C for 4 min, then quenched on ice.
To produce a T1 nuclease ladder, RNA was incubated with T1
ribonuclease in 20 mM sodium acetate (pH 5), 1 mM EDTA, and
7 M urea at 50 C for 15 min, then quenched on ice. Samples were
phenol-extracted and ethanol-precipitated, then resuspended in
formamide for loading.
5¢-32P-RNA was allowed to incubate with and without added
protein (final protein concentrations of 10 nM, 100 nM, and 1
mM) in 10 mM sodium cacodylate (pH 7.0), 100 mM KCl, for 30
min at room temperature, then enzyme was added. Digestion by
nuclease T1 and RNase A was carried out under single-cleavage
conditions, at 37 C for 5 min. Samples were diluted with water,
phenol-extracted and ethanol-precipitated, resuspended in formamide, and run on 10% polyacrylamide/8 M urea gels. Gels were
dried and imaged with a PhosphorImager. Probing was repeated
with different RNA and protein preparations.
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